Physician profile
Christopher J Palombo
NPI 1639179039
$467.90
in general payments reported to CMS, 2019-2025
15 companies · $15.89 in 2025
The $15.89 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $65.13 · 2021: $15.59 · 2022: $61.36 · 2023: $17.16 · 2024: $49.43 · 2025: $15.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $98.74 | 2019-2021 | |
| Hologic Sales and Service, LLC | $73.57 | 2019-2020 | |
| Minerva Surgical, INC | $61.36 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $34.75 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $26.38 | 2024 | Rebyota |
| Allergan, INC. | $26.29 | 2019 | |
| Astellas Pharma US INC | $23.05 | 2024 | Veozah |
| Duchesnay USA Incorporated | $23.01 | 2019 | |
| Pfizer INC. | $17.16 | 2023 | |
| Ethicon US, LLC | $15.90 | 2019 | |
| Organon LLC | $15.89 | 2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $14.97 | 2019 | |
| Therapeuticsmd, INC. | $13.60 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.07 | 2019 | |
| Lupin INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Palombo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.